CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 55 enrolled
Drug / intervention
Aspirin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01976806
NCT01976806Phase 2Completed
CompareCT.gov

The Effects of Docosahexaenoic Acid on Periodontitis in Adults: A Pilot Randomized Controlled Trial

Beth Israel Deaconess Medical Center·interventional·Posted Nov 6, 2013·Updated Dec 13, 2017

In Brief

A Phase 2 clinical trial evaluating Aspirin, Docosahexaenoic acid, and 1 other intervention for Periodontitis and 2 related conditions. Completed, enrolled 55 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether docosahexaenoic acid (DHA) is effective in the treatment of periodontitis in adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontitis, Gingivitis, Inflammation
CountriesUnited States
CollaboratorsNational Center for Research Resources (NCRR), Harvard Medical School (HMS and HSDM)

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 6, 2013
Enrollment StartJun 1, 2009
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.7 years ago

Interventions

Aspirindrug

Docosahexaenoic aciddrug

Placebo (for Docosahexaenoic acid)drug

Placebo (corn/soybean oil) capsules manufactured to look identical to DHA capsules